21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development--Written Testimony and link to watch hearing tomorrow

21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development

   

Friday, September 19, 2014 - 9:00am

Health

2123 Rayburn

Background Documents and Information: 

Hearing Notice

Background Memo

Witnesses: 

Panel I

Dr. Janet Woodcock, Director

• Center for Drug Evaluation and Research
• U.S. Food and Drug Administration
• Witness Testimony (Truth in Testimony and CV)

Panel II

Dr. Kenneth J. Hillan

• Chief Executive Officer
• Achaogen, Inc.
• Witness Testimony (Truth in Testimony and CV)

Dr. Barbara E. Murray

• President
• Infectious Diseases Society of America
• Witness Testimony (Truth in Testimony and CV)

Mr. Kevin Outterson

• Professor of Law
• Boston University School of Law
• Witness Testimony (Truth in Testimony and CV)

Dr. Adrian Thomas

• Vice President, Global Market Access and Public Health
• Janssen Global Services, LLC
• Witness Testimony (Truth in Testimony and CV)

Mr. Allan Coukell

• Director, Medical Programs
• Pew Health Group
• The Pew Charitable Trusts
• Witness Testimony (Truth in Testimony and CV)

Dr. John H. Powers

• Assistant Clinical Professor of Medicine
• George Washington University School of Medicine
• Witness Testimony (Truth in Testimony and CV)

Congress: 

113th

- See more at: http://energycommerce.house.gov/hearing/21st-century-cures-examining-ways-combat-antibiotic-resistance-and-foster-new-drug#sthash.3wykwHoH.dpuf